USPTO trademark

LOVIPTUS

RegisteredUSPTOWord markClass 5

"LOVIPTUS" is a word mark owned by Glaxo Group Limited, filed at the USPTO on April 11, 2019. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
LOVIPTUS trademark as filed
As filed with the USPTO
Status
Registered
Since May 26, 2020
Filed
April 11, 2019
Registered
May 26, 2020
Expires
Not recorded
Application no.
88381574
Registration no.
6061829
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns LOVIPTUS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Christopher M. Hanes

Glaxosmithkline

Goods and services

What the mark covers

The products and services LOVIPTUS is filed for, grouped by Nice class.

  • Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Courtesy reminder - sec. 8 (6-yr) e-mailed
  2. Teas change of correspondence received
  3. Attorney/dom.rep.revoked and/or appointed
  4. Teas revoke/app/change addr of atty/dom rep received
  5. Applicant/correspondence changes (non-responsive) entered
  6. Teas change of owner address received
  7. Applicant/correspondence changes (non-responsive) entered
  8. Teas change of correspondence received
  9. Attorney/dom.rep.revoked and/or appointed
  10. Teas revoke/app/change addr of atty/dom rep received

10 earlier steps on the official record.

FAQ

About LOVIPTUS

Who owns the trademark "LOVIPTUS"?

The USPTO trademark "LOVIPTUS" (application 88381574) is owned by Glaxo Group Limited.

What is the status of "LOVIPTUS"?

Its status at the USPTO is: registered.

When was "LOVIPTUS" registered?

It was registered on May 26, 2020.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull LOVIPTUS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a72-265d-753b-80c4-9fc22467e487
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a72-265d-753b-80c4-9fc22467e487",
  "object": "trademark",
  "mark_text": "LOVIPTUS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "88381574",
  "filing_date": "2019-04-11",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}